Tech Beetle briefing
US
Establishment Labs to Present at 44th Annual J.P. Morgan Healthcare Conference
Essential brief
Establishment Labs to Present at 44th Annual J.P. Morgan Healthcare Conference
Key facts
Establishment Labs is a global medical technology company specializing in breast aesthetics and reconstruction.
The company will present at the influential 44th Annual J.P. Morgan Healthcare Conference, led by CEO Peter Caldin.
The conference offers a platform to showcase innovations, strategic updates, and engage with investors.
Participation underscores Establishment Labs’ leadership and growth ambitions in women’s health technology.
The company aims to leverage the event to expand its market presence and enhance shareholder value.
Highlights
Establishment Labs is a global medical technology company specializing in breast aesthetics and reconstruction.
The company will present at the influential 44th Annual J.P. Morgan Healthcare Conference, led by CEO Peter Caldin.
The conference offers a platform to showcase innovations, strategic updates, and engage with investors.
Participation underscores Establishment Labs’ leadership and growth ambitions in women’s health technology.
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breas
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that Peter Caldin